Activation of β-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation

B Bierie, M Nozawa, JP Renou, JM Shillingford… - Oncogene, 2003 - nature.com
The Wnt/β-catenin signaling pathway is critical for normal mammalian development, the
specification of epidermal cells and neoplastic transformation of intestinal epithelium …

Medicine at mass gatherings: current progress of preparedness of emergency medical services and disaster medical response during 2020 Tokyo Olympic and …

N Morimura, Y Mizobata, M Sugita… - Acute Medicine & …, 2021 - Wiley Online Library
Mass gatherings are events characterized by “the concentration of people at a specific
location for a specific purpose over a set period of time that have the potential to strain the …

Activation of different Wnt/β-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors

K Miyoshi, A Rosner, M Nozawa, C Byrd, F Morgan… - Oncogene, 2002 - nature.com
The Wnt/β-catenin signaling pathway controls cell fate and neoplastic transformation.
Expression of an endogenous stabilized β-catenin (ΔE3 β-catenin) in mammary epithelium …

[HTML][HTML] A phase 2 randomized controlled trial of personalized peptide vaccine immunotherapy with low-dose dexamethasone versus dexamethasone alone in …

K Yoshimura, T Minami, M Nozawa, T Kimura… - European urology, 2016 - Elsevier
Background It is well known that the prognosis of castration-resistant prostate cancer
(CRPC) is poor, and several immunotherapeutic strategies have been applied to the clinical …

Bacillus Calmette–Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract

N Nonomura, Y Ono, M Nozawa, T Fukui, Y Harada… - European …, 2000 - karger.com
Objectives: The aim of this study is to evaluate the efficacy and safety of intrarenal bacillus
Calmette–Guérin (BCG) instillation as a treatment for transitional cell carcinoma in situ (CIS) …

Characteristics and outcomes of accidental hypothermia in Japan: the J-Point registry

T Matsuyama, S Morita, N Ehara, N Miyamae… - Emergency Medicine …, 2018 - emj.bmj.com
Background Accidental hypothermia (AH) has higher incidence and mortality in geriatric
populations. Japan has a rapidly ageing population, and little is known about the …

Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients

Y Tomita, K Tatsugami, N Nakaigawa… - … Journal of Urology, 2020 - Wiley Online Library
Objectives To evaluate the efficacy and safety of cabozantinib, through a bridging study to
METEOR, in Japanese patients with advanced renal cell carcinoma who had progressed …

Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

K Harada, M Nozawa, M Uemura… - … Journal of Urology, 2019 - Wiley Online Library
Objectives To clarify treatment patterns and outcomes for patients with unresectable or
metastatic renal cell carcinoma in the molecular target therapy era in Japan. Methods A …

[HTML][HTML] A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real …

N Hinata, J Yonese, S Masui, Y Nakai… - International Journal of …, 2020 - Springer
Background In a phase III clinical trial, CheckMate 025, treatment of metastatic renal cell
carcinoma (mRCC) with nivolumab demonstrated superior efficacy over everolimus …

Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial

M Shiota, H Miyake, M Takahashi, M Oya… - Cancer Immunology …, 2023 - Springer
Background Anti-PD-1 antibodies are widely used for cancer treatment including advanced
renal cell carcinoma (RCC). However, their therapeutic and adverse effects vary among …